BC Advantage - 2022 Issue 9
Orthopoxvirus and Monkeypox Coding and Guidance
Subscribe or sign in to view the full article.
Article Overview
This article explains recent CPT additions tied to orthopoxvirus laboratory testing and vaccination products associated with monkeypox and smallpox. It is relevant for coding, billing, and compliance teams that need to stay current with CPT category I changes and microbiology/pathology reporting updates. The article also notes the AMA source and focuses on the general reporting landscape for these services.
Why This Topic Matters
These CPT updates affect how certain laboratory tests and vaccine products are identified in medical coding workflows, making the article useful for keeping charge capture, claim preparation, and code set references aligned with current guidance.
Article Sections
-
Category I and Pathology and Laboratory/Microbiology
Introduces the CPT category and service area addressed by the article, with emphasis on laboratory and microbiology reporting.
-
Unique CPT Codes Approved for Smallpox and Monkeypox Immunizations
Summarizes the CPT additions related to vaccination products associated with smallpox and monkeypox reporting.
What You Will Learn
- Which CPT update categories are discussed in the article
- What general areas of reporting are affected by the new CPT additions
- How the article frames testing and immunization coding updates for orthopoxvirus-related services
- Which organizations or editorial bodies are associated with the coding changes
Who Should Read This
- Medical coders
- Coding compliance staff
- Billing specialists
- Practice managers
- Laboratory billing teams
- Immunization documentation staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com